Apmonia Therapeutics
Entity

  • Apmonia Therapeutics

    Created in 2019
  • BETA

    Trend leader (A+)
    Existing signals make this entity one of the most dynamic startups

  • Social networks

    3,016

  • Activities

    biotech deeptech

  • Technologies

    Synthetic Biology

  • Entity types

    Startup

  • Location

    2 Esp. Roland Garros, 51100 Reims, France

    Reims

    France

  • Employees

    Scale: 2-10

    Estimated: 19

  • SIREN

    849959390

  • Engaged corporates

    30
    12 20

  • Added in Motherbase

    2 years, 1 month ago
Description
  • Value proposition

    Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies.

    Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Our innovative technological approach is to target tumors overexpressing matricellular protein thrombospondin-1 (TSP-1).

    Our long-term vision is to develop personalized immunotherapy approaches combining a proprietary therapeutic peptide targeting TSP-1 (namely TAX2 peptide) and a companion diagnostic kit, which may enable patient stratification for TAX2 therapy eligibility based on the monitoring of circulating TSP-1.

    immunologie and oncologie

  • Original language

    Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies.

    Apmonia Therapeutics SAS is a biotechnology company dedicated to developing anti-cancer immunotherapy strategies. Our innovative technological approach is to target tumors overexpressing matricellular protein thrombospondin-1 (TSP-1).

    Our long-term vision is to develop personalized immunotherapy approaches combining a proprietary therapeutic peptide targeting TSP-1 (namely TAX2 peptide) and a companion diagnostic kit, which may enable patient stratification for TAX2 therapy eligibility based on the monitoring of circulating TSP-1.

Corporate interactions BETA
Corporate TypeTweets Articles
SATT CONECTUS
SATT CONECTUS
Research, Research Services
SATT CONECTUS
Research, Research Services 		Other

19 Jul 2024


CNRS
CNRS
Research, Research Services
CNRS
Research, Research Services 		Other

19 Nov 2024


SEMIA
SEMIA
Startup accelerator & VC, Business Consulting and Services
SEMIA
Startup accelerator & VC, Business Consulting and Services 		Other

31 Aug 2022


Gustave Roussy
Gustave Roussy
Health, Hospitals and Health Care
Gustave Roussy
Health, Hospitals and Health Care 		Other

19 Nov 2024


Medicen Paris Region
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations
Medicen Paris Region
Public business cluster, French Cluster, Civic and Social Organizations 		Other

19 Nov 2024


BioValley France
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research
BioValley France
Public business cluster, Biotechnology, French Cluster, Biotechnology Research 		Other

19 Nov 2024


Business France
Business France
National and local authorities, Government Administration
Business France
National and local authorities, Government Administration 		Other

6 Jan 2023


EY
EY
Consulting, audit, IT Services and IT Consulting
EY
Consulting, audit, IT Services and IT Consulting 		Other

11 Oct 2022


CNRS Innovation
CNRS Innovation
Research, Research Services
CNRS Innovation
Research, Research Services 		Other

7 Aug 2024


Bpifrance
Bpifrance
Bank, Banking
Bpifrance
Bank, Banking 		Other

19 Nov 2024


Similar entities
Last news
Show all articles
Social network dynamics